Skip to content
10-Q

Quarterly Report

Aligos Therapeutics, Inc. ALGS

0000950170-25-104042

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 10.35M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.4M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 6.27M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 6.25M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$36.41M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$42.24M
Short Term Investments Q2 2025 · Jun 30, 2025 $104.28M
Short Term Investments Q2 2025 · Dec 31, 2024 $19.94M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $18.66M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $37M
Stockholders Equity Q2 2025 · Jun 30, 2025 $101.87M
Stockholders Equity Q2 2025 · Mar 31, 2025 $116.45M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$28.97M
Stockholders Equity Q2 2025 · Jun 30, 2024 $67.23M
Stockholders Equity Q2 2025 · Mar 31, 2024 $59.8M
Stockholders Equity Q2 2025 · Dec 31, 2023 $92.08M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.27M
Current Liabilities Q2 2025 · Dec 31, 2024 $21.74M
Total Liabilities Q2 2025 · Jun 30, 2025 $32.84M
Total Liabilities Q2 2025 · Dec 31, 2024 $99.07M
Current Assets Q2 2025 · Jun 30, 2025 $127.94M
Current Assets Q2 2025 · Dec 31, 2024 $62.14M
Total Assets Q2 2025 · Jun 30, 2025 $134.71M
Total Assets Q2 2025 · Dec 31, 2024 $70.09M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.53
Eps Diluted Q2 2025 · Jun 30, 2025 $2.90
Eps Diluted restated Q2 2025 · Jun 30, 2024 $0.81
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4.77
Eps Basic Q2 2025 · Jun 30, 2025 −$1.53
Eps Basic Q2 2025 · Jun 30, 2025 $2.90
Eps Basic restated Q2 2025 · Jun 30, 2024 $0.81
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4.77
Sga Expense Q2 2025 · Jun 30, 2025 $5.56M
Sga Expense Q2 2025 · Jun 30, 2025 $10.61M
Sga Expense Q2 2025 · Jun 30, 2024 $6.38M
Sga Expense Q2 2025 · Jun 30, 2024 $13.04M
Rd Expense Q2 2025 · Jun 30, 2025 $13.98M
Rd Expense Q2 2025 · Jun 30, 2025 $28.48M
Rd Expense Q2 2025 · Jun 30, 2024 $21.1M
Rd Expense Q2 2025 · Jun 30, 2024 $37.46M
Net Income Q2 2025 · Jun 30, 2025 −$15.86M
Net Income Q2 2025 · Jun 30, 2025 $27.23M
Net Income Q2 2025 · Mar 31, 2025 $43.09M
Net Income Q2 2025 · Jun 30, 2024 $5.06M
Net Income Q2 2025 · Jun 30, 2024 −$29.8M
Net Income Q2 2025 · Mar 31, 2024 −$34.86M
Operating Income Q2 2025 · Jun 30, 2025 −$18.57M
Operating Income Q2 2025 · Jun 30, 2025 −$37.81M
Operating Income Q2 2025 · Jun 30, 2024 −$26.41M
Operating Income Q2 2025 · Jun 30, 2024 −$48.46M
Revenue Q2 2025 · Jun 30, 2025 $965K
Revenue Q2 2025 · Jun 30, 2025 $1.28M
Revenue Q2 2025 · Jun 30, 2024 $1.06M
Revenue Q2 2025 · Jun 30, 2024 $1.76M